Figure 7.
(A) No significant differences at the population level between healthy controls (n = 34) and PLN carriers (n = 17) in any of the dilutions. (B) Graphs depict differences in plakoglobin score between controls (n = 34), PLN variant carriers that are preclinical (n = 7), with an ACM (n = 3) or DCM (n = 7) phenotype. ACM PLN patients seem to adhere more to the ACM patients’ pattern of plakoglobin score. PLN; phospholamban, ACM; arrhythmogenic cardiomyopathy, DCM; dilated cardiomyopathy. • indicate individual(s) for the correlation.